​

Amgen (AMGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AMGN Stock Forecast

Amgen (AMGN) stock forecast, based on 37 Wall Street analysts, predicts a 12-month average price target of $347.73, with a high of $432.00 and a low of $185.00. This represents a -0.63% decline from the last price of $349.92.

$150 $210 $270 $330 $390 $450 High: $432 Avg: $347.73 Low: $185 Last Closed Price: $349.92

AMGN Stock Rating

Amgen stock's rating consensus is Buy, based on 37 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 22 Buy (59.46%), 12 Hold (32.43%), 3 Sell (8.11%), and 0 Strong Sell (0.00%).

Buy
Total 37 0 3 12 22 Strong Sell Sell Hold Buy Strong Buy

AMGN Price Target Upside V Benchmarks

TypeNameUpside
StockAmgen-0.63%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks8.38%

Price Target Trends

1M3M12M
# Anlaysts21223
Avg Price Target$352.50$347.17$345.35
Last Closing Price$349.92$349.92$349.92
Upside/Downside0.74%-0.79%-1.31%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2649172133
Feb, 26410152132
Jan, 26410152132
Dec, 25410152132
Nov, 25310152131
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 10, 2026Akash TewariJefferies$350.00$373.08-6.19%0.02%
Mar 05, 2026David RisingerLeerink Partners$355.00$367.60-3.43%1.45%
Feb 19, 2026Barclays$185.00$375.50-50.73%-47.13%
Feb 19, 2026Wells Fargo$375.00$379.73-1.25%7.17%
Feb 18, 2026Piper Sandler$432.00$373.3615.71%23.46%
Feb 11, 2026Mizuho Securities$295.00$364.65-19.10%-15.70%
Feb 04, 2026RBC Capital$360.00$357.290.76%2.88%
Feb 04, 2026Morgan Stanley$309.00$351.81-12.17%-11.69%
Jan 29, 2026Oppenheimer$400.00$343.5716.42%14.31%
Jan 26, 2026UBS$390.00$348.9911.75%11.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 10, 2026JefferiesBuyHoldinitialise
Mar 05, 2026Leerink PartnersMarket PerformMarket Performhold
Feb 18, 2026Piper SandlerOverweightOverweighthold
Feb 04, 2026Bank of America SecuritiesUnderperformUnderperformhold
Feb 04, 2026Cantor FitzgeraldNeutralNeutralhold
Feb 04, 2026RBC CapitalOutperformOutperformhold
Feb 04, 2026Cowen & Co.BuyBuyhold
Feb 04, 2026CitigroupNeutralNeutralhold
Jan 29, 2026OppenheimerOutperformOutperformhold
Jan 26, 2026UBSBuyBuyhold

Financial Forecast

EPS Forecast

$5 $11 $17 $23 $29 $35 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.34$12.18$12.56$7.62$14.33---
Avg Forecast$16.82$17.68$18.56$19.59$21.01$21.45$22.22$22.74
High Forecast$17.52$18.41$18.98$19.86$22.39$30.68$31.07$23.91
Low Forecast$16.19$16.80$18.23$19.25$19.62$10.68$16.86$21.04
Surprise %-38.53%-31.11%-32.33%-61.10%-31.79%---

Revenue Forecast

$25B $28B $31B $34B $37B $40B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$25.98B$26.32B$28.19B$33.42B$36.75B---
Avg Forecast$26.00B$26.17B$28.12B$33.20B$34.61B$35.07B$35.60B$36.33B
High Forecast$26.84B$27.00B$28.29B$33.48B$35.96B$35.08B$35.66B$37.75B
Low Forecast$25.25B$25.17B$27.97B$32.91B$32.45B$35.06B$35.55B$34.23B
Surprise %-0.09%0.58%0.26%0.68%6.18%---

Net Income Forecast

$0 $4B $8B $12B $16B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.89B$6.55B$6.72B$4.09B$7.71B---
Avg Forecast$5.71B$6.49B$6.72B$10.52B$11.30B$7.13B$12.89B$12.24B
High Forecast$6.85B$7.79B$8.06B$10.68B$12.05B$16.50B$16.71B$12.86B
Low Forecast$4.56B$5.19B$5.37B$10.36B$10.56B$5.74B$9.07B$11.32B
Surprise %3.29%0.90%--61.12%-31.77%---

AMGN Forecast FAQ

Is Amgen stock a buy?

Amgen stock has a consensus rating of Buy, based on 37 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 22 Buy, 12 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Amgen is a favorable investment for most analysts.

What is Amgen's price target?

Amgen's price target, set by 37 Wall Street analysts, averages $347.73 over the next 12 months. The price target range spans from $185 at the low end to $432 at the high end, suggesting a potential -0.63% change from the previous closing price of $349.92.

How does Amgen stock forecast compare to its benchmarks?

Amgen's stock forecast shows a -0.63% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the drug manufacturers - general stocks industry (8.38%).

What is the breakdown of analyst ratings for Amgen over the past three months?

  • March 2026: 12.12% Strong Buy, 27.27% Buy, 51.52% Hold, 6.06% Sell, 3.03% Strong Sell.
  • February 2026: 12.50% Strong Buy, 31.25% Buy, 46.88% Hold, 6.25% Sell, 3.12% Strong Sell.
  • January 2026: 12.50% Strong Buy, 31.25% Buy, 46.88% Hold, 6.25% Sell, 3.12% Strong Sell.

What is Amgen’s EPS forecast?

Amgen's average annual EPS forecast for its fiscal year ending in December 2026 is $21.45, marking a 49.69% increase from the reported $14.33 in 2025. Estimates for the following years are $22.22 in 2027, and $22.74 in 2028.

What is Amgen’s revenue forecast?

Amgen's average annual revenue forecast for its fiscal year ending in December 2026 is $35.07B, reflecting a -4.57% decrease from the reported $36.75B in 2025. The forecast for 2027 is $35.6B, and $36.33B for 2028.

What is Amgen’s net income forecast?

Amgen's net income forecast for the fiscal year ending in December 2026 stands at $7.13B, representing a -7.56% decrease from the reported $7.71B in 2025. Projections indicate $12.89B in 2027, and $12.24B in 2028.